John Blankenhorn

John Blankenhorn

InvestorPlace Contributor

Expertise: Biochemistry, biotechnology and pharmaceutical research

John Blankenhorn has been a researcher since 2016 and has years of experience and publications on the topics of biochemistry, biotechnology, and pharmaceutical research. His main interests are the application of biology and biotechnology to our daily lives, as well as the use of Machine Learning and AI to speed up research and development in the life sciences. He currently works at Emory University studying the structural basis of Alzheimer’s Disease.

Recent Articles

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

By John Blankenhorn, InvestorPlace Contributor

The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development

By John Blankenhorn, InvestorPlace Contributor

These pharma stock leaders offer revolutionary treatments that could change the world of medicine (and investor's portfolios) for the better.

If You Can Only Buy One Battery Stock in December, It Better Be One of These 3 Names

By John Blankenhorn, InvestorPlace Contributor

These are three of the top battery stocks bringing products of the future to solve the problems of today. Consider picking them up now.

3 Flying Car Stocks That Could Be Multibaggers in the Making

By John Blankenhorn, InvestorPlace Contributor

Flying cars are set to be the wave of the future. Don't let this opportunity to invest in flying car stocks fly away from you.

7 Biotech Stocks to Get In Now Before Investors Catch On

By John Blankenhorn, InvestorPlace Contributor

Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them.

3 Biotech Stocks Ready to Break Out in 2024

By John Blankenhorn, InvestorPlace Contributor

Still, many biotech stocks to buy are positioned well for the coming quarter and new year. These show amazing drug portfolios, promising growth potential, and world-class technology.

The Future of Work: 3 Ways Automation and AI Will Change the Job ÃÛÌÒ´«Ã½

By John Blankenhorn, InvestorPlace Contributor

The future of AI will bring drastic changes to the workplace. Dive into these automation trends, and don't get left behind.

Stable Giants: 3 Bigwig Biotech Stocks for Consistent Returns

By John Blankenhorn, InvestorPlace Contributor

These biotech stocks, Thermo Fisher, Novo Nordisk, and Eli Lilly, will bring consistent returns in the volatile biotech sector.

Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs

By John Blankenhorn, InvestorPlace Contributor

The best drug stocks to buy now are shooting for the moon. These three trailblazers will land among the stars.

The 3 Best Wind Stocks to Buy Now: September 2023

By John Blankenhorn, InvestorPlace Contributor

This clean energy presents a perfect opportunity to take advantage of the explosive growth still to come.

Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend

By John Blankenhorn, InvestorPlace Contributor

Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today.

The 3 Best Machine Learning Stocks to Buy Now: September 2023

By John Blankenhorn, InvestorPlace Contributor

The AI revolution is bringing big gains to machine learning stocks. Here are three of the best to buy right now.

Sky’s the Limit: 3 Stocks Ready to Rocket as Flying Cars Surge

By John Blankenhorn, InvestorPlace Contributor

These three flying car stocks are pushing aggressive timetables with proven aircraft. They may be taking you to your next meeting.

Robo-Lab Stocks: 3 Robotics Companies Changing the Research Game

By John Blankenhorn, InvestorPlace Contributor

Robotics will upend laboratory research just as they upended factories. Bet on the future with these 3 robo-lab company stocks.

3 Beaten-Down Biotech Stocks Bound for a Bounce Back

By John Blankenhorn, InvestorPlace Contributor

Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs.

The GMO Frontier: 3 Synthetic Biology Stocks for Your Must-Buy List

By John Blankenhorn, InvestorPlace Contributor

The industries of the future are already available for investing today. Don't get left behind as synthetic biology stocks build the future.

Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases

By John Blankenhorn, InvestorPlace Contributor

Treating rare diseases is a tough but potentially lucrative business. With clinical trials coming due, here are three stocks to buy.

The 3 Most Undervalued AI Chip Stocks to Buy Now: August 2023

By John Blankenhorn, InvestorPlace Contributor

Many AI chip stocks have soared to unprecedented heights in 2023. But here are 3 undervalued AI chip stocks you might have missed.

The Rise of AI: 3 ChatGPT Stocks You Shouldn’t Miss Out On

By John Blankenhorn, InvestorPlace Contributor

Investors can't invest in ChatGPT directly, but here are the three best AI stocks you can get in on and ride the wave.

3 Space Stocks You’ll Regret Not Buying Soon

By John Blankenhorn, InvestorPlace Contributor

The 21st century will be the time of space travel. Ride the rocket with these top space stocks, or you'll kick yourself for missing out.

Biotech Bonanza: 3 Top DNA Stocks With Revolutionary Potential

By John Blankenhorn, InvestorPlace Contributor

DNA powers almost all biotechnology applications today. These leading DNA stocks are ready to reap the rewards of a growing industry.

Ride the Quantum Computing Wave to Riches With These 3 Promising Stock Picks

By John Blankenhorn, InvestorPlace Contributor

Quantum computing is the wave of the future. So here are 3 of the most promising quantum computing stocks to buy.

3 Cheap Battery Stocks That Smart Investors Will Snap Up Now

By John Blankenhorn, InvestorPlace Contributor

The cheapest battery stocks to buy aren't penny stocks. They're companies offering growth, dividend and guaranteed earnings.

Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil

By John Blankenhorn, InvestorPlace Contributor

There is opportunity in a crisis. Key biotech stocks amid turmoil could be the greatest deals on the market today.

3 Biotech Stocks to Buy Before Drug Trials End

By John Blankenhorn, InvestorPlace Contributor

Drug trials are a chance for high risk, high reward investing. These stocks doing neurodegenerative trials could be set for big gains.

The 3 Best Self-Driving Car Stocks to Buy In July

By John Blankenhorn, InvestorPlace Contributor

Here are 3 self-driving car stocks to add to your portfolio if you see the mode of transportation as the wave of the future.

3 Metaverse Stocks That Should Make Your July Must-Sell List

By John Blankenhorn, InvestorPlace Contributor

The AI hype has superseded the metaverse hype. So now is a good time to clean out your portfolio and sell these three metaverse stocks.

Time to Evolve: 3 Synthetic Biology Stocks to Sell Off Now

By John Blankenhorn, InvestorPlace Contributor

The biotech boom has become a biotech bust. Many companies still have further to fall, so sell these three before they hit rock bottom.

Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom

By John Blankenhorn, InvestorPlace Contributor

AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider.

3 EV Stocks That Just Have No More Hope Left

By John Blankenhorn, InvestorPlace Contributor

Not every electric vehicle company will survive. Here are three EV stocks you'll want to sell before they go bankrupt or just fade away.

3 Millionaire-Maker Next-Gen Telecom Stocks to Buy and Hold Forever

By John Blankenhorn, InvestorPlace Contributor

The next millionaire-maker telecom stocks may not be ones you've heard about. Don't miss out on a generational opportunity.

3 Millionaire-Maker Machine Learning Stocks to Buy And Hold Forever

By John Blankenhorn, InvestorPlace Contributor

The AI revolution is already transforming both art and science. Here's three stocks which will also transform your portfolio.

3 Cloud Computing Stocks to Buy With Explosive Upside Potential

By John Blankenhorn, InvestorPlace Contributor

The best cloud computing stocks of tomorrow may not come from among the current dominant cloud companies. Here are three to look out for.

Top 3 Agricultural and Heavy-Duty Machinery Companies to Watch

By John Blankenhorn, InvestorPlace Contributor

Agricultural machinery stocks are key to making more with less. Good for sustainability, good for beating inflation, good for investors.

3 Gene Testing Stocks to Buy Before They Take Off

By John Blankenhorn, InvestorPlace Contributor

The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry.

The 3 Best Agribusiness Stocks to Buy for June 2023

By John Blankenhorn, InvestorPlace Contributor

People will always need food. Here are the best agribusiness stocks leveraging technology and innovation to bring you the food you need.

3 Small-Cap Drug Stocks to Watch as Their Clinical Trials End Soon

By John Blankenhorn, InvestorPlace Contributor

These three small companies could become gold or lead depending on the outcomes of their clinical trials making them top drug stocks to watch.

3 Solar Stocks to Buy Now or Regret Missing the Next Big Boom

By John Blankenhorn, InvestorPlace Contributor

As nations rush to meet their climate goals, solar power is becoming the energy of choice. And that means big gains for solar stocks.

The 3 Best Biofuel Stocks to Buy Now

By John Blankenhorn, InvestorPlace Contributor

Biofuels are the energy of choice to replace oil, using the same infrastructure but burning more cleanly. Here are thee companies to watch.

3 Metaverse Stocks to Sell as They Fail to Deliver

By John Blankenhorn, InvestorPlace Contributor

The metaverse hasn't lived up to the hype, so don't get caught out when these metaverse stocks drop hard and fast as they fail to deliver.

3 Hydrogen Stocks to Make You the Millionaire Next Door

By John Blankenhorn, InvestorPlace Contributor

Hydrogen is booming as both a green source of energy and an industrial feedstock for our most important chemicals. Don't miss out on the gains available.

The 3 Quantum Computing Stocks You Need to Own Now for Maximum Returns

By John Blankenhorn, InvestorPlace Contributor

Finding the best quantum computing stocks to buy is critical because this is clearly the next big industry.

Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich … or Broke.

By John Blankenhorn, InvestorPlace Contributor

These biotech companies are swinging for the fences. They may hit homers, they may strike out. But you'll definitely want to watch them.

3 Personalized Medicine Stocks to Buy for Long-Time Returns

By John Blankenhorn, InvestorPlace Contributor

Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out.

3 DNA Stocks to Buy for the Synthetic Biology Revolution

By John Blankenhorn, InvestorPlace Contributor

Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche.

The 3 Most Promising Energy Storage Stocks for April 2023 

By John Blankenhorn, InvestorPlace Contributor

Here are three energy storage stocks from companies who are delivering the scale needed to help renewable energy efforts possible.

The 3 Most Promising Gene Editing Stocks to Buy in 2023

By John Blankenhorn, InvestorPlace Contributor

Intellia, Beam, and Editas are using gene editing to cure incurable diseases. These are three gene editing stocks you'll want to invest in.

3 Cash-Rich Biotech Stocks to Bet on for the Long Haul

By John Blankenhorn, InvestorPlace Contributor

Cash rich biotech stocks can survive while most of their peers struggle with rising interest rates. Here are three to watch.

3 Biotech Stocks to Sell Before They’re 6 Feet Under

By John Blankenhorn, InvestorPlace Contributor

Biotech stocks with no earnings, no cash, and no path to profit will have no chance at survival. Here's three such biotech stocks to avoid.

3 Stocks to Buy That Could Be the Next Gaming Phenomenon

By John Blankenhorn, InvestorPlace Contributor

Gaming is fun, and gaming stocks can be profitable. Here's three stocks with the tech and the art to be gaming phenomena.

Load More